Guth, B D <br/><br/>
DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs.  [electronic resource] 

 -  Basic research in cardiology  Jun 1997 
 - 181-90 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0300-8428 
<br/><br/><label>Standard No.: </label>10.1007/BF00788635  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aspirin--pharmacology<br/>Biphenyl Compounds--pharmacology<br/>Chlorobenzenes--pharmacology<br/>Coronary Thrombosis--prevention & control<br/>Cyclooxygenase Inhibitors--pharmacology<br/>Dogs<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Heptanoic Acids--pharmacology<br/>Male<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Pyridines--pharmacology<br/>Receptors, Thromboxane--antagonists & inhibitors<br/>Thromboxane-A Synthase--antagonists & inhibitors